Health Care & Life Sciences » Pharmaceuticals | CMG Pharmaceutical Co. Ltd.

CMG Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
20,402
22,753
27,042
32,970
41,536
Cost of Goods Sold (COGS) incl. D&A
12,472
14,627
17,713
20,126
24,173
Gross Income
7,930
8,126
9,329
12,844
17,363
SG&A Expense
6,959
7,445
11,698
11,091
14,559
EBIT
828
445
-
1,521
2,332
Unusual Expense
17
33
1,287
92
3,806
Non Operating Income/Expense
196
401
179
60
193
Interest Expense
1,134
123
80
-
-
Pretax Income
311
158
3,649
1,642
151
Income Tax
-
-
-
51
35
Consolidated Net Income
311
158
3,649
1,693
187
Net Income
311
158
3,649
1,693
187
Net Income After Extraordinaries
326
158
3,647
1,659
187
Net Income Available to Common
296
158
3,650
1,728
187
EPS (Basic)
3.87
1.69
38.90
18.91
2.00
Basic Shares Outstanding
77
93
94
91
109
EPS (Diluted)
4.69
1.80
38.90
18.91
1.72
Diluted Shares Outstanding
83
94
94
91
109
EBITDA
1,944
1,910
990
3,575
4,203
Other Operating Expense
143
235
203
232
472
Non-Operating Interest Income
797
270
110
154
1,129

About CMG Pharmaceutical Co.

View Profile
Address
14 Dosan-daero 66-gil
Seoul SL 06064
Korea, Republic Of
Employees -
Website http://www.cmgpharma.co.kr
Updated 09/14/2018
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. Its products include medicine in the form of tablets, capsules, and oral thin film. The company was founded on August 1, 2001 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.